The outcomes demonstrated the effective transport of siRNA and mRNA to DCs in the lymph nodes, which prompted CD8+ T cells to mount a targeted immune response against TRP-2, which significantly slowed down tumor development in mice models (157). This evidence concerns the gene CD8A and neoplasm.